No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

EFAVIR Sustiva

No Prescription » Prescription Drugs 6 » EFAVIR Sustiva

Treating HIV infection in combination with other medicines. If Efavirenz is taken alone to treat HIV it may stop working.Efavirenz (eh-FAH-vih-rehnz) is used with other medicines in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).Efavirenz will not cure or prevent HIV infection or AIDS; however it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems that usually result from AIDS or HIV disease. Efavirenz will not keep you from spreading HIV to other people. People who receive this medicine may continue to have some of the problems usually related to AIDS or HIV disease.Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by blocking the growth of HIV.Efavirenz is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your body.Efavirenz is used to treat HIV which causes the acquired immunodeficiency syndrome (AIDS). Efavirenz is not a cure for HIV or AIDS.Efavirenz is one of the growing number of drugs used to fight HIV infection. HIV the human immunodeficiency virus weakens the immune system until it can no longer fight off infections leading to the fatal disease known as AIDS (acquired immune deficiency syndrome).Like other drugs for HIV Efavirenz works by impairing the virus's ability to multiply. However when taken alone it may prompt the virus to become resistant. Efavirenz is therefore always taken with at least one other HIV medication such as Retrovir or Crixivan. Even when used properly it may remain effective for only a limited time.

Buy EFAVIR Sustiva and other Prescription Drugs 6 products online at Medstore.

Buy Online at Medstore - Click Here!

About EFAVIR Sustiva:

Product Type: Prescription Drugs 6

EFAVIR ( Sustiva Generic Efavirenz )

EFAVIR (Sustiva Generic Efavirenz)

Sustiva Generic Efavirenz

200mg 30 Capsules 60 Capsules 600mg 30 Tablets 60(2 x 30) Tablets Sustiva Generic Efavirenz EFAVIR

View more Prescription Drugs 6

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.